AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2550704005

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

About this item

Full title

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

Publisher

New York: NASDAQ OMX Corporate Solutions, Inc

Journal title

NASDAQ OMX's News Release Distribution Channel, 2021

Language

English

Formats

Newsletter articles

Publication information

Publisher

New York: NASDAQ OMX Corporate Solutions, Inc

Subjects

Subjects and topics

More information

Alternative Titles

Full title

AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_2550704005

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_2550704005

How to access this item

Log in as a Library member

View record in ProQuest

View in old catalogue

Connecting people and collections

Indigenous engagement

Celebrating and sharing stories of Indigenous Australia, and helping to locate and prioritise Indigenous voices in the Library's collections.

Learning

Resources and programs for school and university students, teachers, families and lifelong learners.

Stories

Showcasing people, places and ideas inspired by the collection and the library community.